Clinical Trial Update: Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer [Phase 1]

View source ↗

Summary

The NCI-sponsored Phase 1 trial of temsirolimus with hormone therapy for relapsed prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Hormone therapy
• Torisel (Temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 1 | Status: TERMINATED